GEN1053
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEN1053, covering 2025-04-22 to 2025-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy [Phase 1, Phase 2]